Anest. intenziv. Med. 2007;18(3):164-169
Extended immunologic profile taken during the first days in the ICU and the prognosis of patients requiring long-term intensive careIntensive Care Medicine - Original Paper
- 1 Anesteziologicko-resuscitační klinika Fakultní nemocnice u svaté Anny v Brně
- 2 Ústav imunologie a alergologie Fakultní nemocnice u svaté Anny v Brně
Objective:
To establish the predictive value of an extended spectrum of immunologic parameters measured during the initial ICU days on the ICU survival of patients requiring long-term intensive care.
Design:
Prospective, clinical study.
Setting:
Department Anaesthesia and Intensive Care, St. Anna University Hospital, Brno, Czech Republic.
Material and methods:
The immune profile was taken in patients estimated to stay in the ICU > 3 days in 5- day intervals. In this paper we report on the trends of TNF-alpha production of the whole blood after LPS stimulation (TNF-alpha), plasma IL-6 and IL-10 concentrations and T-lymphocyte activation (CD3+HLADR+) in the first 5 days of ICU stay. The relationship of the immunologic parameters to ICU mortality, type of admission (surgical, medical, trauma, CPR) and APACHE II is also reported.
Results:
167 patients were studied [M/F 113/54; mean age 63 (53; 73) years]. 137 survived their ICU stay (S) and 30 died (NS). APACHE II on admission was 27 (21; 33). On day 1 the production of TNF-alpha differed in the S and NS groups [> 1000 pg/ml (752; > 1000) and 870 pg/ml (542; > 1000) respectively; p < 0.05] as did the IL-10 concentration [6.2 pg/ml (5; 18) and 19 pg/ml (5.4; 63) respectively; p=0.005]. In the patients remaining in the ICU on day 5 (n=125) the change in TNF-α between day 1 and day 5 (delta TNF-α) did not differ between the S and NS groups.There was no significant difference between TNF-alpha between the S and NS groups on day 5 [in group S TNF-alpha production increased from > 1000 pg/ml (752; > 1000) to > 1000 pg/ml (> 1000; > 1000) and in group NS from 870 pg/ml (542; >1000) to > 1000 pg/ml (785; > 1000)]. IL-6 decreased in the NS group more slowly and therefore a significant difference in concentrations on day 5 was measured (p = 0.001). In group S a decrease from 74 pg/ml (32; 178) to 29.8 pg/ml (14.1; 57.4) and in group NS from 88 pg/ml (34; 681) to 66.5 pg/ml (43; 109) was measured. Patients with TNF-alpha production < 1000 pg/ml on day 1 had significantly greater mortality (p < 0.05) as did those with IL-10 > 9.2 pg/ml on day 1 (p = 0.06) and day 5 (p = 0.09). IL-6 >75 pg/ml predicted ICU death. No clinically significant association was found between any immunologic parameter and APACHE II on ICU admission.
Conclusion:
The extended immune spectrum (TNF-alpha production of the whole blood after LPS stimulation, IL-10 and IL-6 plasma concentrations) has a predictive value in the heterogeneous population of longterm ICU patients.
Keywords: intensive; immunoparalysis; TNF-alpha; interleukin 6; interleukin 10; APACHE II; outcome
Published: June 1, 2007 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Nierhaus, A., Montag, B., Timmler, N. et al. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med., 2003, 29, p. 646-651.
Go to original source...
Go to PubMed...
- Monneret, G., Lepape, A., Voirin, N. et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med., 2006, 32, p. 1175-1183.
Go to original source...
Go to PubMed...
- Průcha, M., Herold, I., Zazula, R. et al. Monocytární deaktivace a produkce tumor nekrotizujícího faktoru ex vivo - prognostické parametry pacientů jednotek intenzivní péče. Anest. intenziv. Med., 2003, 14, s. 223-227.
- Monneret, G., Finck, M. E., Venet, F. et al. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol. Lett., 2004, 95, p. 193-198.
Go to original source...
Go to PubMed...
- Ploder, M., Pelinka, L., Schmuckenschlager, C. et al. Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock, 2006, 25, p. 129-134.
Go to PubMed...
- Oczenski, W., Krenn, H., Jilch, R. et al. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med., 2003, 29, p. 1253-1257.
Go to original source...
Go to PubMed...
- Allen, M. L., Peters, M. J., Goldman, A. et al. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit. Care Med., 2002, 30, p. 1140-1145.
Go to original source...
Go to PubMed...
- Allen, M. L., Hoschtitzky, J. A., Peters, M. J. et al. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit. Care Med., 2006, 34, p. 2658-2665.
Go to original source...
Go to PubMed...
- Patel, R. T., Deen, K. I., Youngs, D. et al. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br. J. Surg., 1994, 81, p. 1306-1308.
Go to original source...
Go to PubMed...
- Geppert, A., Dorninger, A., Delle-Karth, G. et al. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit. Care Med., 2006, 34, p. 2035-2042.
Go to original source...
Go to PubMed...
- Taniguchi, T., Koido, Y., Aiboshi, J. et al. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit. Care Med., 1999, 27, p. 1262-1264.
Go to original source...
Go to PubMed...
- Watanabe, E., Hirasawa, H., Oda, S. et al. Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications. J. Trauma, 2005, 59, p. 1181-1189.
Go to original source...
Go to PubMed...
- Meduri, G. U., Headley, S., Kohler, G. et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest, 1995, 107, p. 1062-1073.
Go to original source...
Go to PubMed...
- Holzheimer, R. G., Capel, P., Cavaillon, J. M. et al. Immunological surrogate parameters in a prognostic model for multi-organ failure and death. Eur. J. Med. Res., 2000, 5, p. 283-294.
- Stimac, D., Fisic, E., Milic, S. et al. Prognostic values of IL-6, IL-8, and IL-10 in acute pancreatitis. J. Clin. Gastroenterol., 2006, 40, p. 209-212.
Go to original source...
Go to PubMed...
- Marchant, A., Alegre, M. L., Hakim, A. et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J. Clin. Immunol., 1995, 15, p. 266-273.
Go to original source...
Go to PubMed...
- Dadak, L., Stouracova, M., Stetka, P., Sramek, V. Monocyte function (CD14+HLA-DR+) during first ICU days in long term ICU patients. Intensive Care Med., 2005, 31, suppl 1, S14.
- Dadák, L., Štouračová, M., Štětka, P., Kuklínek, P. Šrámek V. Aktivace monocytů během prvních dnů pobytu na JIP jako predikční marker přežití. Anest. intenziv. Med., 2007, 18, 3, s. 170-174.
- Hack, C. E., De Groot, E. R., Felt-Bersma, R. J. et al. Increased plasma levels of interleukin-6 in sepsis. Blood, 1989, 74, p. 1704-1710.
Go to original source...
- Calandra, T., Gerain, J., Heumann, D. et al. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am. J. Med., 1991, 91, p. 23-29.
Go to original source...
Go to PubMed...
- Damas, P., Ledoux, D., Nys, M. et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg., 1992, 215, p. 356-362.
Go to original source...
Go to PubMed...
- Casey, L. C., Balk, R. A., Bone, R. C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med., 1993, 119, p. 771-778.
Go to original source...
Go to PubMed...
- Reinhart, K., Menges, T., Gardlund, B. et al. Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit. Care Med., 2001, 29, p. 765-769.
Go to original source...
Go to PubMed...
- Hynninen, M., Pettila, V., Takkunen, O. et al. Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock, 2003, 20, p. 1-4.
Go to original source...
Go to PubMed...
- Lowe, P. R., Galley, H. F., Abdel-Fattah, A., Webster, N. R. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit. Care Med., 2003, 31, p. 34-38.
Go to original source...
Go to PubMed...
- Venet, F., Bohe, J., Debard, A. L. et al. Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock. Crit. Care Med., 2005, 33, p. 2836-2840.
Go to original source...
Go to PubMed...
- Monneret, G., Debard, A. L., Venet, F. et al. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit. Care Med., 2003, 31, p. 2068-2071.
Go to original source...
Go to PubMed...
- Weiss, M., Voglic, S., Harms-Schirra, B. et al. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission. Intensive Care Med., 2003, 29, p. 904-914.
Go to original source...
Go to PubMed...
- Keh, D., Boehnke, T., Weber-Cartens, S. et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am. J. Respir. Crit. Care Med., 2003, 167, p. 512-520.
Go to original source...
Go to PubMed...
- Moller, H. J., Moestrup, S. K., Weis, N.et al. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163. Crit. Care Med., 2006, 34, p. 2561-2566.
Go to original source...
Go to PubMed...
- Pangault, C., Le Tulzo, Y., Tattevin, P. et al. Down-modulation of granulocyte macrophage-colony stimulating factor receptor on monocytes during human septic shock. Crit. Care Med., 2006, 34, p. 1193-1201.
Go to original source...
Go to PubMed...
- Fumeaux, T., Dufour, J., Stern, S., Pugin, J. Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines. Intensive Care Med., 2004, 30, p. 2028-2037.
Go to original source...
Go to PubMed...
- Clark, M. F., Baudouin, S. V. A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med., 2006, 32, p. 1706-1712.
Go to original source...
Go to PubMed...
- Volk, D. H., Reinke, P., Döcke, W. D. Immunostimulation with cytokines in patients with "immunoparalysis". In Marshall, J. C., Cohen, J. (Eds). Immune response in the critically ill. Berlín : Springer-Verlag 2000, p. 393-404.
Go to original source...
- Záhorec, R. Diagnostika a monitorovanie septického syndromu - laboratorne skóre imunitnej zápalovej odpovede. Anest. neodkl. Péče. 2001, 12. Suppl. 1, s. 16-23.